SYNARTRO
Synartro is a Swedish research and development company that develops improved treatments using patented delivery technology combined with existing proven drugs. The preclinical lead program, SYN321, is based on a novel therapy combining diclofenac covalently bound to hyaluronan for the treatment of osteoarthritis (OA), a disease that today leaves up to 50% of patients without adequate pain relief. The company’s initial focus is in knee OA with the potential of further expansion.
SYNARTRO
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2011-01-01
Address:
Uppsala, Uppsala Lan, Sweden
Country:
Sweden
Website Url:
http://www.synartro.com
Total Employee:
1+
Status:
Active
Total Funding:
5.67 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API WordPress LetsEncrypt SSL By Default Font Awesome IPv6
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
bionat italia
bionat italia is a research and development company.
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Prommune
Prommune is a research and development company.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Summit Therapeutics
Summit Therapeutics is a clinical-stage drug discovery and development company.
TEKNEIDOS
TEKNEIDOS is a research and development company.
UD-GenoMed
UD-GenoMed is a research and development company and service laboratory.
Current Employees Featured
Founder
Investors List
Official Site Inspections
http://www.synartro.com Semrush global rank: 10.5 M Semrush visits lastest month: 227
- Host name: webfront2.webcluster.loopia.se
- IP address: 93.188.2.52
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Synartro"
Synartro – Novel treatments for osteoarthritis
Synartro AB. Synartro is a Swedish life science company developing local injection treatments to provide superior and sustained efficacy without systemic side-effects. This is achieved by …See details»
Synartro - Crunchbase Company Profile & Funding
Synartro is a Swedish research and development company that develops improved treatments using patented delivery technology combined with …See details»
Synartro - LinkedIn
Synartro is a Swedish pharmaceutical company developing local injection treatments aiming to provide superior and sustained efficacy without systemic side-effects.See details»
Investors – Synartro
Synartro is a Swedish life science company developing local injection treatments that provide superior and sustained efficacy without systemic side-effects. This is achieved by chemically …See details»
Synartro 2025 Company Profile: Valuation, Investors, Acquisition ...
Synartro General Information Description. Developer of drugs and a drug delivery platform designed to treat osteoarthritis in humans and animals. The company develops local injection …See details»
Synartro AB Company Profile | Uppsala, Uppsala, Sweden
Find company research, competitor information, contact details & financial data for Synartro AB of Uppsala, Uppsala. Get the latest business insights from Dun & Bradstreet.See details»
Synartro Company Profile - Office Locations, Competitors ... - Craft
Synartro is a research and development company that focuses on treatments for osteoarthritis (OA). It uses a patented delivery technology in combination with existing proven drugs. …See details»
Board of Directors – Synartro
Maria Nyhage. MSc. Maria has 25 years’ experience within life science. Former head of Q-Med/Galderma’s global business development and co-founder of Nordic Medical Solutions …See details»
Synartro - Funding, Financials, Valuation & Investors - Crunchbase
Synartro is a research and development company. How much funding has this organization raised over time? ShowSee details»
Synartro - Company Profile - Tracxn
Feb 28, 2025 Synartro has been granted regulatory and ethical approval for the first clinical trial of lead compound SYN321 for treatment of symptomatic knee osteoarthritisCision • Apr 27, …See details»
Synartro - Company profile | ensun
The patent filed by Synartro in 2015 was initially approved in the US in May 2020, in Europe in 2021 and Canada in 2022. Synartro is a Swedish life science company developing local …See details»
Synartro - VentureRadar
Synartro is a Swedish research and development company that develops improved treatments using patented delivery technology combined with existing proven drugs. The preclinical lead …See details»
Synartro (company) - Nordic 9
Synartro (company). Synartro is a Swedish research and development company that develops improved treatments using patented delivery technology combined with existing proven drugs. …See details»
Synartro - Products, Competitors, Financials, Employees, …
Synartro AB Thu, Apr 27, 2023 13:40 CET Synartro announces that the company has been granted approval from the Swedish Medical Products Agency and the Swedish Ethical Review …See details»
Synartro - CoBee Company Profile & Funding Rounds
Synartro is a Swedish research and development company that develops improved treatments using patented delivery technology combined with existing proven drugs. The preclinical lead …See details»
Sciety invests in Synartro that develops novel therapy for …
Oct 25, 2021 Synartro develops a novel therapy for knee osteoarthritis–a powerful combination of an anti-inflammatory drug and hyaluronic acid that is a natural lubricant for the joint. The …See details»
Synartro | VentureRadar
Synartro is a Swedish research and development company that develops improved treatments using patented delivery technology combined with existing proven drugs. The preclinical lead …See details»
The Sciety syndicate invests in Synartro that develops a novel drug …
May 4, 2020 Synartro’s vision is to contribute to better quality of life for people suffering from osteoarthritis. Osteoarthritis affects more than 240 million people globally and is one of the …See details»
Technology & Development - Synartro
Synartro plans to manufacture trial product and start the clinical trial in 2024. The clinical trial approval was received in 2023. Patent. The patent filed by Synartro in 2015 was initially …See details»
Sutro Biopharma Announces Strategic Portfolio Review Resulting …
Mar 13, 2025 Organization: Headcount and Operations: As part of this restructuring, Sutro will reduce its organizational headcount by nearly 50 percent. These changes are in process and …See details»